Factors in successful radiofrequency ablation therapy for malignant liver tumors

Hepato-Gastroenterology

Volumn 51, Issue 60, 2004, Pages 1761-1765

  Sakakima, Yoshikazu ^a   Inoue, Soichiro ^a   Takeda, Shin ^a   Kaneko, Tetsuya ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Malignant liver tumors; Number of nodules; Radiofrequency ablation therapy (RFA); Tumor diameter

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; AGED; CANCER SURVIVAL; CATHETER ABLATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER METASTASIS; LIVER NODULE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION THERAPY; RECURRENT CANCER; REVIEW; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 6344254385     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Steven AC, Francesco I, Francesco C: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999; 230:1-8.
2. Christian R, Gregory JG: Loco-regional management of hepatocellular carcinoma. Clin Liver Dis 2001; 5:161-173.
3. Yale DP, Ginard H, David KI: Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: technique and technical considerations. Am Surg 2001; 67:1181-1184.
4. Namiki I, Yasuhiro A, Nobuyuki E: Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001; 91:949-956.
5. Richard JB, David PA, Anton JB: Radiofrequency ablation in 477 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10:52-58.
6. Long RJ, Paul DH, Nagy H: Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999; 177:303-306.
7. Lian-Xin L, Hong-Chi J, Da-Xun P: Radiofrequency ablation of liver cancers. World J Gastroenterol 2002; 8:393-399.
8. Hong-Chi J, Lian-Xin L, Lin-Feng W: Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002; 8:624-630.
9. Steven AC, Francesco I, Paolo V: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232:381-391.
10. Bradford JW, Jeffrey RR, Stephen KL: Percutaneous tumor ablation with radiofrequency. Cancer 2002; 94:443-451.
11. Raymond PC, Murray A, Steven G: Radiofrequency ablation of malignant hepatic neoplasms. Can Assoc Radiol J 2002; 53:272-278.
12. Boris WK, David MO: Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002; 132:605-612.
13. The Cancer of the Liver Italian Program (CLIP) Investigators: A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28:751-755.
14. Nakao A, Virji A, Starzl E: Abnormal prothrombin (DES-γ-Carboxy Prothrombin) in hepatocellular carcinoma. Hepatogastroenterology 1991; 38:450-453.
15. Soichiro I, Akimasa N, Hiroshi T: Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am J Gastroenterol 1994; 89:2222-2226.
16. Akimasa N, Kenji T, Hiroshi T: Usefulness of simultaneously determination of α-Fetoprotein and Des-γ-Carboxy Prothrombin in hepatocellular carcinoma. Semin Surg Oncol 1996; 12:160-163.
17. David AI, Damian ED, Brian M: Hepatic radiofrequency ablation. Arch Surg 2002; 137:422-427.
18. Charles HS, Shung IL, David AO: Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177:411-417.
19. Takahiro Y, Fumie K, Kiwamu O: Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001; 91:1342-1348.
20. Yasunari S, Toyohito I, Toshiharu M: Clinicopathological analysis of risk factors for the development of hepatocellular carcinoma after surgery for esophageal varices due to underlying cirrhosis or pre-cirrhosis in 397 patients. Hepatol Res 2003; 25:62-70.
21. T Koh, H Taniguchi, H Yamagishi: Are both PIVKA-II and α-Fetoprotein necessary in follow-up management after hepatic resection for hepatocellular carcinoma? Hepatogastroenterology 2002; 49:1615-1618.